Going beyond 60 years of D2 blockers: new treatments for psychosis
Professor of Molecular Psychiatry Oliver Howes from King's College London shares recent findings on the role of dopamine and neuroinflammation in the development of psychosis, the effects of antipsychotic drugs and the causes of cognitive impairments. Find out about an exciting new research study (ATLANTIS) launching this year to test a new treatment with CPFT patients.
▶︎
New paradigms for the negative symptoms
▶︎
PGC: Genes for schizophrenia - Robin Murray
▶︎
Emerging Advances in the Treatment of Cognitive Impairment Associated With Schizophrenia
▶︎
Taking Amlodipine, Losartan, or Lisinopril for Blood Pressure? Here's What Many Seniors Don't Know
▶︎
Introduction to Suture
▶︎
Schizophrenia and Dopamine (Level 3 - Advanced)
▶︎
Tapering Psychiatric Medications Safely: Insights with Dr. Josef
▶︎
Psychosis and Schizophrenia with Professor Paul Fletcher
▶︎
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
▶︎
A new approach for treating schizophrenia | Wellcome
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
How to Focus to Change Your Brain | Huberman Lab Essentials
▶︎
The Truth About Antidepressant Withdrawal Symptoms
▶︎
Advances in Schizophrenia Treatment
▶︎
The World's Leading Autism Expert - Professor Sir Simon Baron-Cohen
▶︎
How psychosis bends your reality - BBC
▶︎
Understanding Trauma and Psychosis
▶︎
Paul Fletcher: Perception and Deception in the Psychotic Brain (full version)
▶︎
Is High-Dose Olanzapine an Option for Treatment-Resistant Schizophrenia?
▶︎